Friday, 26th August Australian Diabetes Society and the Australian Diabetes Educators Association Annual Scientific Meeting 2016

6:30AM - 8:30AM
Sponsored by:

Attend the Novo Nordisk Trade Stand to confirm your registration and collect your running number

 

Arrival & Warm up: 6:30am | Start Time: 6:45am

Location: Kurrawa Park, Old Burleigh Road (end of Victoria Avenue Shopping Mall, near Kurrawa Surf Club)

Broadbeach, QLD  4000

Novo Nordisk welcomes participants of all fitness. The course is approximately 5kms in distance and it will be one lap of the course.

Please note that only healthcare professional who are registered delegates of the ASD-ADEA ASM 2016 can participate in the Fun Run/ Walk.

ResizedImage11999-Changing-diabetes.png                                                     ResizedImage11796-novo-nordisk.png

 

7:00AM - 8:00AM
Room 8
Sponsored by:

Clinical Debate - Gold standard in Diabetes Management. Insulin Pump Therapy vs MDI
Speakers: Mark Forbes and Dr Michael d'Emden

A Healthcare Professional debate on the merits of Insulin Pump Therapy and Multiple Daily Injections, based on the examination of Australian patient case studies. Key points addressed will focus on patient outcomes, lifestyle implications, glucose monitoring options through review of CareLink patient data. 
Topics covered: 
1. Merits of Insulin Pump Therapy and Multiple Daily Injections
2. Patient outcomes, lifestyle implications, glucose monitoring, CareLink date review


Visit the ADS ADEA Conference website for more detail- http://ads-adea.org.au/industry-trade-breakfast-symposia/

7:30AM - 8:30AM
Room 5
Sponsored by:

'Accurate Blood Glucose Meters’ - Clinical and practical approach to new International Standards
Speaker: 
A/Prof Kittie Wyne

This practical presentation aims to simplify the new accuracy standards (ISO 15197:2013) by outlining the real impact on patient’s management with case study scenarios and to compare the accuracy of the most commonly used blood glucose meters in Australia and around the world. 
It will also introduce the ‘Contour NEXT’ blood glucose meter from Ascensia Diabetes Car.
For patients with diabetes, regular monitoring of blood glucose levels is an essential part of managing their diabetes therapy. Self-monitoring of BG (SMBG) is recommended especially for patients treated with multiple daily insulin injections or using an insulin pump. Devices for SMBG are thus daily companions for patients who have to rely on the values being precise and reliable enough to ensure an adequate glycemic control, especially when they calculate their insulin doses on the basis of current BG levels. If displayed BG values are, for example, higher than the true BG concentration, this might conceal hypoglycemia or lead to an inappropriately high insulin dose that might induce hypoglycemia.


Visit the ADS ADEA Conference website for more detail- http://ads-adea.org.au/industry-trade-breakfast-symposia/

 

7:30AM - 8:30AM
Central B
Sponsored by:

Add-on therapy in Type 2 Diabetes: What is safe?
Speaker:
Dr Konrad Kangru 

Primary care in Type 2 diabetes, especially without the additional support of an Endocrinologist or Diabetes clinic, can be a challenge for many isolated, regional and rural clinicians. Added to this are the issues of Cardiovascular safety for this group of patients, already at increased risk of adverse CV outcomes. For many GPs and Diabetes Educators without a large Diabetes patient population, the need to avoid harm to our patients may become a barrier to providing optimal care.

In this session, Dr Konrad Kangru, a rural GP from Proserpine, Queensland, will explain the implications of recent Cardiovascular safety trials for the patients we deal with every day. They will help you to understand these studies, and share insights into how to interpret their findings to increase your confidence in managing patients with Diabetes as they progress beyond oral hypoglycaemic management alone

Topics Covered
Topic 1:  Management of Type 2 Diabetes patients in rural areas
Topic 2:  Interpreting cardiovascular safety trial results for the management of Type 2 Diabetes patients


Visit the ADS ADEA Conference website for more detail- http://ads-adea.org.au/industry-trade-breakfast-symposia/

7:30AM - 8:30AM
Rooms 6 & 7
Sponsored by:

Detecting vision-threatening diabetic retinopathy with the RETeval-DR electroretinography/pupillography system
Speaker:
Prof Quentin Davis

Diabetic retinopathy (DR) is a major cause of blindness worldwide, due in part to the challenge of detecting vision-threatening diabetic retinopathy (VTDR) in time for effective intervention. Contributing factors to low VTDR detection include patient characteristics (low compliance to the recommended annual dilated eye examination and patient aversion to eye dilation) and test method characteristics (significant failure rates and low sensitivity). 

This presentation describes results from four clinical trials using the hand-held RETeval-DR device (Welch-Allyn, USA) for detecting VTDR. The RETeval-DR device measures an electroretinogram (ERG) and a pupillary response, both of which are well established to be affected by VTDR, and combines the information into a numerical value for VTDR detection. Four trials using five trial sites have tested 880 subjects (241 positive subjects) in the United States, United Kingdom, and Japan.  Weighting the reported sensitivity / specificity from each trial by the number of subjects, the sensitivity and specificity for the detection of VTDR is 88% and 69% respectively. Testing time, in any patient setting, is under 5 minutes and is non-mydriatic, non-invasive, providing immediate objective results, which may improve testing compliance. Concluding, the RETeval-DR device may reduce blindness from diabetic retinopathy by improving the detection of VTDR.

Topics Covered
Topic 1: Diabetic retinopathy
Topic 2: Clinical trial results for the detection of vision-threatening diabetic retinopathy


Visit the ADS ADEA Conference website for more detail- http://ads-adea.org.au/industry-trade-breakfast-symposia/

8:30AM - 10:00AM
Room 9
Chair: Debra Singh

Aim:

The aim is for participants to think and make a plan to standardize Diabetes Education and treatment for children

Overview:

Angie Llewellyn - Making changes and the challenges of standardising care faced by health professional in the work place- 10 mins

Deb Foskett - Making a difference that lasts a life time

Angela Llewellyn -  Brainstorming ideas with the group and overcoming hurdles

Scenarios of 2 different types of care that were implemented

What Angie and Deb did in their workplaces

Learning Outcomes:

  • Ability to identify issues in their own workplace
  • Make a plan to standardize care in their workplace
  • To see diabetes from a different point of view- ie parents and children

*NB: If you wish to attend this workshop, please ensure you arrive on time as places are limited

8:30AM - 10:30AM
Organisers office
Chair: Tracy Aylen

Morning tea provided

9:00AM - 11:00AM
Central B
Chairs: Jane Holmes-Walker & Sandra Neoh
10:00AM - 11:00AM
Room 9

Aim:

The aim of the interactive workshop is to take participants on a life affirming journey:

  • To promote discussion around travel safety for people with diabetes on insulin.
  • To explore innovative solutions to unique situations not routinely covered in guidelines or travel advisories.

Overview:

- PowerPoint presentation that will facilitate interactive discussion around points of relevance to travelling.

- The sharing of images and anecdotes supporting the narrative.

- This will be an interactive, informal storytelling of real events and the lessons learned.

- Comments, questions and suggestions will be invited from the floor.

- Sam Beattie will add value by extrapolating the discussion to include CSII in addition to GKs MDI experience

Learning objectives:

At the end of the workshop participants will be able to:

  • Application of current travel related guidelines for PWD on insulin
  • Improvisation when circumstances encountered are not covered by the ADEA and RACGP travel guidelines
  • Ways to empower PWD around applying basic principles to when encountering complex or unusual circumstances.

*NB: If you wish to attend this masterclass, please ensure you arrive on time as places are limited

10:45AM - 11:30AM
Exhibition
11:15AM - 12:15PM
Arena 1

*NB: Due to the short time frame between session changes, please ensure you head to the Exhibition area to grab some morning tea prior to heading to Arena 1 for the AGM.   

 

12:15PM - 12:45PM
Arena 1
12:45PM - 1:15PM
Arena 1
11:30AM - 1:00PM
Central A
Chairs: Glynis Ross & Leonie Callaway
Sponsored by:
1:00PM - 2:00PM
Exhibition
1:00PM - 2:00PM
Room 5

Lunch provided 

*NB: to participate you must be a member of this ADEA Special Interest Group

1:00PM - 2:00PM
Organisers office
Chairs: Joanne Ramadge & Elizabeth Obersteller

Lunch provided

1:15PM - 2:00PM
Central A
Chair: Mark Cooper
1:00PM - 5:30PM
Rooms 8&9

(lunch provided)

2:00PM - 3:30PM
Arena 1
Chair: Gary Deed
Sponsored by:
2:00PM - 3:30PM
Organisers office

Afternoon tea provided

3:30PM - 4:00PM
Arena 1

Assistant Minister for Health The Hon. Ken Wyatt AM